TY - JOUR AU - Manning, G. AU - Whyte, D. B. AU - Martinez, R. AU - Hunter, T. AU - Sudarsanam, S. PY - 2002 DA - 2002// TI - The protein kinase complement of the human genome JO - Science VL - 298 UR - https://doi.org/10.1126/science.1075762 DO - 10.1126/science.1075762 ID - Manning2002 ER - TY - JOUR AU - Robinson, D. R. AU - Wu, Y. M. AU - Lin, S. F. PY - 2000 DA - 2000// TI - The protein tyrosine kinase family of the human genome JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203957 DO - 10.1038/sj.onc.1203957 ID - Robinson2000 ER - TY - JOUR AU - Hubbard, S. R. PY - 1999 DA - 1999// TI - Structural analysis of receptor tyrosine kinases JO - Prog Biophys Mol Biol VL - 71 UR - https://doi.org/10.1016/S0079-6107(98)00047-9 DO - 10.1016/S0079-6107(98)00047-9 ID - Hubbard1999 ER - TY - JOUR AU - Vogelstein, B. AU - Papadopoulos, N. AU - Velculescu, V. E. AU - Zhou, S. AU - Diaz, L. A. AU - Kinzler, K. W. PY - 2013 DA - 2013// TI - Cancer genome landscapes JO - Science VL - 339 UR - https://doi.org/10.1126/science.1235122 DO - 10.1126/science.1235122 ID - Vogelstein2013 ER - TY - JOUR AU - Schlessinger, J. PY - 2000 DA - 2000// TI - Cell signaling by receptor tyrosine kinases JO - Cell VL - 103 UR - https://doi.org/10.1016/S0092-8674(00)00114-8 DO - 10.1016/S0092-8674(00)00114-8 ID - Schlessinger2000 ER - TY - JOUR AU - Lemmon, M. A. AU - Schlessinger, J. PY - 2010 DA - 2010// TI - Cell signaling by receptor tyrosine kinases JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.06.011 DO - 10.1016/j.cell.2010.06.011 ID - Lemmon2010 ER - TY - JOUR AU - Pawson, T. AU - Gish, G. D. AU - Nash, P. PY - 2001 DA - 2001// TI - SH2 domains, interaction modules and cellular wiring JO - Trends Cell Biol VL - 11 UR - https://doi.org/10.1016/S0962-8924(01)02154-7 DO - 10.1016/S0962-8924(01)02154-7 ID - Pawson2001 ER - TY - JOUR AU - Wehrman, T. AU - He, X. AU - Raab, B. AU - Dukipatti, A. AU - Blau, H. AU - Garcia, K. C. PY - 2007 DA - 2007// TI - Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors JO - Neuron VL - 53 UR - https://doi.org/10.1016/j.neuron.2006.09.034 DO - 10.1016/j.neuron.2006.09.034 ID - Wehrman2007 ER - TY - JOUR AU - Zhang, X. AU - Gureasko, J. AU - Shen, K. AU - Cole, P. A. AU - Kuriyan, J. PY - 2006 DA - 2006// TI - An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor JO - Cell VL - 125 UR - https://doi.org/10.1016/j.cell.2006.05.013 DO - 10.1016/j.cell.2006.05.013 ID - Zhang2006 ER - TY - JOUR AU - Yuzawa, S. AU - Opatowsky, Y. AU - Zhang, Z. AU - Mandiyan, V. AU - Lax, I. AU - Schlessinger, J. PY - 2007 DA - 2007// TI - Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor JO - Cell VL - 130 UR - https://doi.org/10.1016/j.cell.2007.05.055 DO - 10.1016/j.cell.2007.05.055 ID - Yuzawa2007 ER - TY - JOUR AU - Yayon, A. AU - Klagsbrun, M. AU - Esko, J. D. AU - Leder, P. AU - Ornitz, D. M. PY - 1991 DA - 1991// TI - Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor JO - Cell VL - 64 UR - https://doi.org/10.1016/0092-8674(91)90512-W DO - 10.1016/0092-8674(91)90512-W ID - Yayon1991 ER - TY - JOUR AU - Schlessinger, J. AU - Plotnikov, A. N. AU - Ibrahimi, O. A. AU - Eliseenkova, A. V. AU - Yeh, B. K. AU - Yayon, A. PY - 2000 DA - 2000// TI - Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization JO - Mol Cell VL - 6 UR - https://doi.org/10.1016/S1097-2765(00)00073-3 DO - 10.1016/S1097-2765(00)00073-3 ID - Schlessinger2000 ER - TY - JOUR AU - Chung, I. AU - Akita, R. AU - Vandlen, R. AU - Toomre, D. AU - Schlessinger, J. AU - Mellman, I. PY - 2010 DA - 2010// TI - Spatial control of EGF receptor activation by reversible dimerization on living cells JO - Nature VL - 464 UR - https://doi.org/10.1038/nature08827 DO - 10.1038/nature08827 ID - Chung2010 ER - TY - JOUR AU - Soos, M. A. AU - Field, C. E. AU - Siddle, K. PY - 1993 DA - 1993// TI - Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity JO - Biochem J VL - 290 UR - https://doi.org/10.1042/bj2900419 DO - 10.1042/bj2900419 ID - Soos1993 ER - TY - JOUR AU - Pandini, G. AU - Frasca, F. AU - Mineo, R. AU - Sciacca, L. AU - Vigneri, R. AU - Belfiore, A. PY - 2002 DA - 2002// TI - Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M202766200 DO - 10.1074/jbc.M202766200 ID - Pandini2002 ER - TY - JOUR AU - Ogiso, H. AU - Ishitani, R. AU - Nureki, O. AU - Fukai, S. AU - Yamanaka, M. AU - Kim, J. H. PY - 2002 DA - 2002// TI - Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains JO - Cell VL - 110 UR - https://doi.org/10.1016/S0092-8674(02)00963-7 DO - 10.1016/S0092-8674(02)00963-7 ID - Ogiso2002 ER - TY - JOUR AU - Stauber, D. J. AU - DiGabriele, A. D. AU - Hendrickson, W. A. PY - 2000 DA - 2000// TI - Structural interactions of fibroblast growth factor receptor with its ligands JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.97.1.49 DO - 10.1073/pnas.97.1.49 ID - Stauber2000 ER - TY - JOUR AU - Burgess, A. W. AU - Cho, H. S. AU - Eigenbrot, C. AU - Ferguson, K. M. AU - Garrett, T. P. AU - Leahy, D. J. PY - 2003 DA - 2003// TI - An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors JO - Mol Cell VL - 12 UR - https://doi.org/10.1016/S1097-2765(03)00350-2 DO - 10.1016/S1097-2765(03)00350-2 ID - Burgess2003 ER - TY - JOUR AU - Shewchuk, L. M. AU - Hassell, A. M. AU - Ellis, B. AU - Holmes, W. D. AU - Davis, R. AU - Horne, E. L. PY - 2000 DA - 2000// TI - Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail JO - Structure VL - 8 UR - https://doi.org/10.1016/S0969-2126(00)00516-5 DO - 10.1016/S0969-2126(00)00516-5 ID - Shewchuk2000 ER - TY - JOUR AU - Wybenga-Groot, L. E. AU - Baskin, B. AU - Ong, S. H. AU - Tong, J. AU - Pawson, T. AU - Sicheri, F. PY - 2001 DA - 2001// TI - Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region JO - Cell VL - 106 UR - https://doi.org/10.1016/S0092-8674(01)00496-2 DO - 10.1016/S0092-8674(01)00496-2 ID - Wybenga-Groot2001 ER - TY - JOUR AU - Huse, M. AU - Kuriyan, J. PY - 2002 DA - 2002// TI - The conformational plasticity of protein kinases JO - Cell VL - 109 UR - https://doi.org/10.1016/S0092-8674(02)00741-9 DO - 10.1016/S0092-8674(02)00741-9 ID - Huse2002 ER - TY - JOUR AU - Nolen, B. AU - Taylor, S. AU - Ghosh, G. PY - 2004 DA - 2004// TI - Regulation of protein kinases; controlling activity through activation segment conformation JO - Mol Cell VL - 15 UR - https://doi.org/10.1016/j.molcel.2004.08.024 DO - 10.1016/j.molcel.2004.08.024 ID - Nolen2004 ER - TY - JOUR AU - Mol, C. D. AU - Dougan, D. R. AU - Schneider, T. R. AU - Skene, R. J. AU - Kraus, M. L. AU - Scheibe, D. N. PY - 2004 DA - 2004// TI - Structural basis for the autoinhibition and STI-571 inhibition of c-kit tyrosine kinase JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M403319200 DO - 10.1074/jbc.M403319200 ID - Mol2004 ER - TY - JOUR AU - Red Brewer, M. AU - Choi, S. H. AU - Alvarado, D. AU - Moravcevic, K. AU - Pozzi, A. AU - Lemmon, M. A. PY - 2009 DA - 2009// TI - The juxtamembrane region of the EGF receptor functions as an activation domain JO - Mol Cell VL - 34 UR - https://doi.org/10.1016/j.molcel.2009.04.034 DO - 10.1016/j.molcel.2009.04.034 ID - Red Brewer2009 ER - TY - JOUR AU - Jura, N. AU - Endres, N. F. AU - Engel, K. AU - Deindl, S. AU - Das, R. AU - Lamers, M. H. PY - 2009 DA - 2009// TI - Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment JO - Cell VL - 137 UR - https://doi.org/10.1016/j.cell.2009.04.025 DO - 10.1016/j.cell.2009.04.025 ID - Jura2009 ER - TY - JOUR AU - Brummer, T. AU - Schmitz-Peiffer, C. AU - Daly, R. J. PY - 2010 DA - 2010// TI - Docking proteins JO - FEBS J VL - 277 UR - https://doi.org/10.1111/j.1742-4658.2010.07865.x DO - 10.1111/j.1742-4658.2010.07865.x ID - Brummer2010 ER - TY - JOUR AU - Ostman, A. AU - Bohmer, F. D. PY - 2001 DA - 2001// TI - Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases JO - Trends Cell Biol VL - 11 UR - https://doi.org/10.1016/S0962-8924(01)01990-0 DO - 10.1016/S0962-8924(01)01990-0 ID - Ostman2001 ER - TY - JOUR AU - Casaletto, J. B. AU - McClatchey, A. I. PY - 2012 DA - 2012// TI - Spatial regulation of receptor tyrosine kinases in development and cancer JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3277 DO - 10.1038/nrc3277 ID - Casaletto2012 ER - TY - JOUR AU - McDonell, L. M. AU - Kernohan, K. D. AU - Boycott, K. M. AU - Sawyer, S. L. PY - 2015 DA - 2015// TI - Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin JO - Hum Mol Genet VL - 24 UR - https://doi.org/10.1093/hmg/ddv254 DO - 10.1093/hmg/ddv254 ID - McDonell2015 ER - TY - JOUR AU - Lahiry, P. AU - Torkamani, A. AU - Schork, N. J. AU - Hegele, R. A. PY - 2010 DA - 2010// TI - Kinase mutations in human disease: interpreting genotype-phenotype relationships JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2707 DO - 10.1038/nrg2707 ID - Lahiry2010 ER - TY - JOUR AU - Medves, S. AU - Demoulin, J. B. PY - 2012 DA - 2012// TI - Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies JO - J Cell Mol Med VL - 16 UR - https://doi.org/10.1111/j.1582-4934.2011.01415.x DO - 10.1111/j.1582-4934.2011.01415.x ID - Medves2012 ER - TY - JOUR AU - Wang, Z. AU - Longo, P. A. AU - Tarrant, M. K. AU - Kim, K. AU - Head, S. AU - Leahy, D. J. PY - 2011 DA - 2011// TI - Mechanistic insights into the activation of oncogenic forms of EGF receptor JO - Nat Struct Mol Biol VL - 18 UR - https://doi.org/10.1038/nsmb.2168 DO - 10.1038/nsmb.2168 ID - Wang2011 ER - TY - JOUR AU - Sharma, S. V. AU - Bell, D. W. AU - Settleman, J. AU - Haber, D. A. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor mutations in lung cancer JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2088 DO - 10.1038/nrc2088 ID - Sharma2007 ER - TY - JOUR AU - Janne, P. A. AU - Engelman, J. A. AU - Johnson, B. E. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.985 DO - 10.1200/JCO.2005.09.985 ID - Janne2005 ER - TY - JOUR AU - Marchetti, A. AU - Martella, C. AU - Felicioni, L. AU - Barassi, F. AU - Salvatore, S. AU - Chella, A. PY - 2005 DA - 2005// TI - EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.08.043 DO - 10.1200/JCO.2005.08.043 ID - Marchetti2005 ER - TY - JOUR AU - Red Brewer, M. AU - Yun, C. H. AU - Lai, D. AU - Lemmon, M. A. AU - Eck, M. J. AU - Pao, W. PY - 2013 DA - 2013// TI - Mechanism for activation of mutated epidermal growth factor receptors in lung cancer JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1220050110 DO - 10.1073/pnas.1220050110 ID - Red Brewer2013 ER - TY - JOUR AU - Yun, C. H. AU - Boggon, T. J. AU - Li, Y. AU - Woo, M. S. AU - Greulich, H. AU - Meyerson, M. PY - 2007 DA - 2007// TI - Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity JO - Cancer Cell VL - 11 UR - https://doi.org/10.1016/j.ccr.2006.12.017 DO - 10.1016/j.ccr.2006.12.017 ID - Yun2007 ER - TY - JOUR AU - Rosell, R. AU - Carcereny, E. AU - Gervais, R. AU - Vergnenegre, A. AU - Massuti, B. AU - Felip, E. PY - 2012 DA - 2012// TI - Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70393-X DO - 10.1016/S1470-2045(11)70393-X ID - Rosell2012 ER - TY - JOUR AU - Zhou, C. AU - Wu, Y. L. AU - Chen, G. AU - Feng, J. AU - Liu, X. Q. AU - Wang, C. PY - 2011 DA - 2011// TI - Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70184-X DO - 10.1016/S1470-2045(11)70184-X ID - Zhou2011 ER - TY - JOUR AU - Mok, T. S. AU - Wu, Y. L. AU - Thongprasert, S. AU - Yang, C. H. AU - Chu, D. T. AU - Saijo, N. PY - 2009 DA - 2009// TI - Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0810699 DO - 10.1056/NEJMoa0810699 ID - Mok2009 ER - TY - JOUR AU - Mitsudomi, T. AU - Morita, S. AU - Yatabe, Y. AU - Negoro, S. AU - Okamoto, I. AU - Tsurutani, J. PY - 2010 DA - 2010// TI - Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70364-X DO - 10.1016/S1470-2045(09)70364-X ID - Mitsudomi2010 ER - TY - JOUR AU - Maemondo, M. AU - Inoue, A. AU - Kobayashi, K. AU - Sugawara, S. AU - Oizumi, S. AU - Isobe, H. PY - 2010 DA - 2010// TI - Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909530 DO - 10.1056/NEJMoa0909530 ID - Maemondo2010 ER - TY - JOUR AU - Sequist, L. V. AU - Yang, J. C. AU - Yamamoto, N. AU - O'Byrne, K. AU - Hirsh, V. AU - Mok, T. PY - 2013 DA - 2013// TI - Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.2806 DO - 10.1200/JCO.2012.44.2806 ID - Sequist2013 ER - TY - JOUR AU - Janne, P. A. AU - Yang, J. C. AU - Kim, D. W. AU - Planchard, D. AU - Ohe, Y. AU - Ramalingam, S. S. PY - 2015 DA - 2015// TI - AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1411817 DO - 10.1056/NEJMoa1411817 ID - Janne2015 ER - TY - STD TI - Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et al. Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2018;378:113–25. ID - ref45 ER - TY - JOUR AU - Lee, J. C. AU - Vivanco, I. AU - Beroukhim, R. AU - Huang, J. H. AU - Feng, W. L. AU - DeBiasi, R. M. PY - 2006 DA - 2006// TI - Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain JO - PLoS Med VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030485 DO - 10.1371/journal.pmed.0030485 ID - Lee2006 ER - TY - JOUR AU - Arjona, D. AU - Bello, M. J. AU - Alonso, M. E. AU - Aminoso, C. AU - Isla, A. AU - De Campos, J. M. PY - 2005 DA - 2005// TI - Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations JO - Neuropathol Appl Neurobiol VL - 31 UR - https://doi.org/10.1111/j.1365-2990.2005.00653.x DO - 10.1111/j.1365-2990.2005.00653.x ID - Arjona2005 ER - TY - JOUR AU - van den Bent, M. J. AU - Brandes, A. A. AU - Rampling, R. AU - Kouwenhoven, M. C. AU - Kros, J. M. AU - Carpentier, A. F. PY - 2009 DA - 2009// TI - Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034 JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.5984 DO - 10.1200/JCO.2008.17.5984 ID - van den Bent2009 ER - TY - JOUR AU - Franceschi, E. AU - Cavallo, G. AU - Lonardi, S. AU - Magrini, E. AU - Tosoni, A. AU - Grosso, D. PY - 2007 DA - 2007// TI - Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di neuro-Oncologia (GICNO) JO - Br J Cancer VL - 96 UR - https://doi.org/10.1038/sj.bjc.6603669 DO - 10.1038/sj.bjc.6603669 ID - Franceschi2007 ER - TY - JOUR AU - Vivanco, I. AU - Robins, H. I. AU - Rohle, D. AU - Campos, C. AU - Grommes, C. AU - Nghiemphu, P. L. PY - 2012 DA - 2012// TI - Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-11-0284 DO - 10.1158/2159-8290.CD-11-0284 ID - Vivanco2012 ER - TY - JOUR AU - Wu, R. AU - Connolly, D. AU - Ngelangel, C. AU - Bosch, F. X. AU - Munoz, N. AU - Cho, K. R. PY - 2000 DA - 2000// TI - Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203934 DO - 10.1038/sj.onc.1203934 ID - Wu2000 ER - TY - JOUR AU - Robertson, S. C. AU - Meyer, A. N. AU - Hart, K. C. AU - Galvin, B. D. AU - Webster, M. K. AU - Donoghue, D. J. PY - 1998 DA - 1998// TI - Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.8.4567 DO - 10.1073/pnas.95.8.4567 ID - Robertson1998 ER - TY - JOUR AU - Tallini, G. AU - Asa, S. L. PY - 2001 DA - 2001// TI - RET oncogene activation in papillary thyroid carcinoma JO - Adv Anat Pathol VL - 8 UR - https://doi.org/10.1097/00125480-200111000-00005 DO - 10.1097/00125480-200111000-00005 ID - Tallini2001 ER - TY - JOUR AU - Heinrich, M. C. AU - Corless, C. L. AU - Demetri, G. D. AU - Blanke, C. D. AU - von Mehren, M. AU - Joensuu, H. PY - 2003 DA - 2003// TI - Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.04.190 DO - 10.1200/JCO.2003.04.190 ID - Heinrich2003 ER - TY - JOUR AU - Ou, S. I. AU - Schrock, A. B. AU - Bocharov, E. V. AU - Klempner, S. J. AU - Haddad, C. K. AU - Steinecker, G. PY - 2017 DA - 2017// TI - HER2 transmembrane domain (TMD) mutations (V659/G660) that stabilize homo- and Heterodimerization are rare oncogenic drivers in lung adenocarcinoma that respond to Afatinib JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2016.11.2224 DO - 10.1016/j.jtho.2016.11.2224 ID - Ou2017 ER - TY - JOUR AU - Serra, V. AU - Vivancos, A. AU - Puente, X. S. AU - Felip, E. AU - Silberschmidt, D. AU - Caratu, G. PY - 2013 DA - 2013// TI - Clinical response to a lapatinib-based therapy for a li-Fraumeni syndrome patient with a novel HER2V659E mutation JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-13-0132 DO - 10.1158/2159-8290.CD-13-0132 ID - Serra2013 ER - TY - JOUR AU - Bocharov, E. V. AU - Lesovoy, D. M. AU - Pavlov, K. V. AU - Pustovalova, Y. E. AU - Bocharova, O. V. AU - Arseniev, A. S. PY - 1858 DA - 1858// TI - Alternative packing of EGFR transmembrane domain suggests that protein-lipid interactions underlie signal conduction across membrane JO - Biochim Biophys Acta VL - 2016 ID - Bocharov1858 ER - TY - JOUR AU - Yamamoto, H. AU - Higasa, K. AU - Sakaguchi, M. AU - Shien, K. AU - Soh, J. AU - Ichimura, K. PY - 2014 DA - 2014// TI - Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas JO - J Natl Cancer Inst VL - 106 UR - https://doi.org/10.1093/jnci/djt338 DO - 10.1093/jnci/djt338 ID - Yamamoto2014 ER - TY - STD TI - Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, et al. Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E. Oncologist. 2017. https://doi.org/10.1634/theoncologist.2017-0345. ID - ref59 ER - TY - JOUR AU - Heinrich, M. C. AU - Griffith, D. J. AU - Druker, B. J. AU - Wait, C. L. AU - Ott, K. A. AU - Zigler, A. J. PY - 2000 DA - 2000// TI - Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor JO - Blood VL - 96 ID - Heinrich2000 ER - TY - JOUR AU - Buchdunger, E. AU - Cioffi, C. L. AU - Law, N. AU - Stover, D. AU - Ohno-Jones, S. AU - Druker, B. J. PY - 2000 DA - 2000// TI - Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors JO - J Pharmacol Exp Ther VL - 295 ID - Buchdunger2000 ER - TY - JOUR AU - Lopez-Gines, C. AU - Gil-Benso, R. AU - Ferrer-Luna, R. AU - Benito, R. AU - Serna, E. AU - Gonzalez-Darder, J. PY - 2010 DA - 2010// TI - New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile JO - Mod Pathol VL - 23 UR - https://doi.org/10.1038/modpathol.2010.62 DO - 10.1038/modpathol.2010.62 ID - Lopez-Gines2010 ER - TY - JOUR AU - Selvaggi, G. AU - Novello, S. AU - Torri, V. AU - Leonardo, E. AU - De Giuli, P. AU - Borasio, P. PY - 2004 DA - 2004// TI - Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh011 DO - 10.1093/annonc/mdh011 ID - Selvaggi2004 ER - TY - JOUR AU - Hanawa, M. AU - Suzuki, S. AU - Dobashi, Y. AU - Yamane, T. AU - Kono, K. AU - Enomoto, N. PY - 2006 DA - 2006// TI - EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21454 DO - 10.1002/ijc.21454 ID - Hanawa2006 ER - TY - JOUR AU - Rodriguez-Antona, C. AU - Pallares, J. AU - Montero-Conde, C. AU - Inglada-Perez, L. AU - Castelblanco, E. AU - Landa, I. PY - 2010 DA - 2010// TI - Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis JO - Endocr Relat Cancer VL - 17 UR - https://doi.org/10.1677/ERC-08-0304 DO - 10.1677/ERC-08-0304 ID - Rodriguez-Antona2010 ER - TY - JOUR AU - Hirsch, F. R. AU - Varella-Garcia, M. AU - Cappuzzo, F. PY - 2009 DA - 2009// TI - Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2009.199 DO - 10.1038/onc.2009.199 ID - Hirsch2009 ER - TY - JOUR AU - Menard, S. AU - Casalini, P. AU - Campiglio, M. AU - Pupa, S. AU - Agresti, R. AU - Tagliabue, E. PY - 2001 DA - 2001// TI - HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer JO - Ann Oncol VL - 12 UR - https://doi.org/10.1093/annonc/12.suppl_1.S15 DO - 10.1093/annonc/12.suppl_1.S15 ID - Menard2001 ER - TY - JOUR AU - Yaziji, H. AU - Goldstein, L. C. AU - Barry, T. S. AU - Werling, R. AU - Hwang, H. AU - Ellis, G. K. PY - 2004 DA - 2004// TI - HER-2 testing in breast cancer using parallel tissue-based methods JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.16.1972 DO - 10.1001/jama.291.16.1972 ID - Yaziji2004 ER - TY - JOUR AU - Kim, K. C. AU - Koh, Y. W. AU - Chang, H. M. AU - Kim, T. H. AU - Yook, J. H. AU - Kim, B. S. PY - 2011 DA - 2011// TI - Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1695-2 DO - 10.1245/s10434-011-1695-2 ID - Kim2011 ER - TY - JOUR AU - Park, D. I. AU - Yun, J. W. AU - Park, J. H. AU - Oh, S. J. AU - Kim, H. J. AU - Cho, Y. K. PY - 2006 DA - 2006// TI - HER-2/neu amplification is an independent prognostic factor in gastric cancer JO - Dig Dis Sci VL - 51 UR - https://doi.org/10.1007/s10620-005-9057-1 DO - 10.1007/s10620-005-9057-1 ID - Park2006 ER - TY - JOUR AU - Xu, L. AU - Nilsson, M. B. AU - Saintigny, P. AU - Cascone, T. AU - Herynk, M. H. AU - Du, Z. PY - 2010 DA - 2010// TI - Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.16 DO - 10.1038/onc.2010.16 ID - Xu2010 ER - TY - JOUR AU - Ha, S. Y. AU - Lee, J. AU - Kang, S. Y. AU - Do, I. G. AU - Ahn, S. AU - Park, J. O. PY - 2013 DA - 2013// TI - MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas JO - Mod Pathol VL - 26 UR - https://doi.org/10.1038/modpathol.2013.108 DO - 10.1038/modpathol.2013.108 ID - Ha2013 ER - TY - JOUR AU - Carraway, K. L. AU - Sweeney, C. PY - 2002 DA - 2002// TI - EGF receptor activation by heterologous mechanisms JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(02)00076-4 DO - 10.1016/S1535-6108(02)00076-4 ID - Carraway2002 ER - TY - JOUR AU - Ludes-Meyers, J. H. AU - Subler, M. A. AU - Shivakumar, C. V. AU - Munoz, R. M. AU - Jiang, P. AU - Bigger, J. E. PY - 1996 DA - 1996// TI - Transcriptional activation of the human epidermal growth factor receptor promoter by human p53 JO - Mol Cell Biol VL - 16 UR - https://doi.org/10.1128/MCB.16.11.6009 DO - 10.1128/MCB.16.11.6009 ID - Ludes-Meyers1996 ER - TY - JOUR AU - Reznik, T. E. AU - Sang, Y. AU - Ma, Y. AU - Abounader, R. AU - Rosen, E. M. AU - Xia, S. PY - 2008 DA - 2008// TI - Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor JO - Mol Cancer Res VL - 6 UR - https://doi.org/10.1158/1541-7786.MCR-07-0236 DO - 10.1158/1541-7786.MCR-07-0236 ID - Reznik2008 ER - TY - JOUR AU - Sun, T. AU - Aceto, N. AU - Meerbrey, K. L. AU - Kessler, J. D. AU - Zhou, C. AU - Migliaccio, I. PY - 2011 DA - 2011// TI - Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.003 DO - 10.1016/j.cell.2011.02.003 ID - Sun2011 ER - TY - JOUR AU - Maiti, G. P. AU - Mondal, P. AU - Mukherjee, N. AU - Ghosh, A. AU - Ghosh, S. AU - Dey, S. PY - 2013 DA - 2013// TI - Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0063440 DO - 10.1371/journal.pone.0063440 ID - Maiti2013 ER - TY - JOUR AU - Mudduluru, G. AU - Ceppi, P. AU - Kumarswamy, R. AU - Scagliotti, G. V. AU - Papotti, M. AU - Allgayer, H. PY - 2011 DA - 2011// TI - Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2011.13 DO - 10.1038/onc.2011.13 ID - Mudduluru2011 ER - TY - JOUR AU - Templeton, A. J. AU - Diez-Gonzalez, L. AU - Ace, O. AU - Vera-Badillo, F. AU - Seruga, B. AU - Jordan, J. PY - 2014 DA - 2014// TI - Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis JO - Cancer Treat Rev VL - 40 UR - https://doi.org/10.1016/j.ctrv.2014.08.003 DO - 10.1016/j.ctrv.2014.08.003 ID - Templeton2014 ER - TY - JOUR AU - Albertson, D. G. PY - 2006 DA - 2006// TI - Gene amplification in cancer JO - Trends Genet VL - 22 UR - https://doi.org/10.1016/j.tig.2006.06.007 DO - 10.1016/j.tig.2006.06.007 ID - Albertson2006 ER - TY - JOUR AU - Albertson, D. G. AU - Collins, C. AU - McCormick, F. AU - Gray, J. W. PY - 2003 DA - 2003// TI - Chromosome aberrations in solid tumors JO - Nat Genet VL - 34 UR - https://doi.org/10.1038/ng1215 DO - 10.1038/ng1215 ID - Albertson2003 ER - TY - JOUR AU - Dutt, A. AU - Ramos, A. H. AU - Hammerman, P. S. AU - Mermel, C. AU - Cho, J. AU - Sharifnia, T. PY - 2011 DA - 2011// TI - Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0020351 DO - 10.1371/journal.pone.0020351 ID - Dutt2011 ER - TY - JOUR AU - Reis-Filho, J. S. AU - Simpson, P. T. AU - Turner, N. C. AU - Lambros, M. B. AU - Jones, C. AU - Mackay, A. PY - 2006 DA - 2006// TI - FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-1164 DO - 10.1158/1078-0432.CCR-06-1164 ID - Reis-Filho2006 ER - TY - JOUR AU - Helsten, T. AU - Elkin, S. AU - Arthur, E. AU - Tomson, B. N. AU - Carter, J. AU - Kurzrock, R. PY - 2016 DA - 2016// TI - The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-14-3212 DO - 10.1158/1078-0432.CCR-14-3212 ID - Helsten2016 ER - TY - JOUR AU - Fischbach, A. AU - Rogler, A. AU - Erber, R. AU - Stoehr, R. AU - Poulsom, R. AU - Heidenreich, A. PY - 2015 DA - 2015// TI - Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer JO - Histopathology VL - 66 UR - https://doi.org/10.1111/his.12473 DO - 10.1111/his.12473 ID - Fischbach2015 ER - TY - JOUR AU - Kim, J. Y. AU - Jung, H. H. AU - Do, I. G. AU - Bae, S. AU - Lee, S. K. AU - Kim, S. W. PY - 2016 DA - 2016// TI - Prognostic value of ERBB4 expression in patients with triple negative breast cancer JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2195-3 DO - 10.1186/s12885-016-2195-3 ID - Kim2016 ER - TY - JOUR AU - Shi, J. AU - Yao, D. AU - Liu, W. AU - Wang, N. AU - Lv, H. AU - He, N. PY - 2012 DA - 2012// TI - Frequent gene amplification predicts poor prognosis in gastric cancer JO - Int J Mol Sci VL - 13 UR - https://doi.org/10.3390/ijms13044714 DO - 10.3390/ijms13044714 ID - Shi2012 ER - TY - JOUR AU - Moreira, R. B. AU - Peixoto, R. D. AU - de Sousa Cruz, M. R. PY - 2015 DA - 2015// TI - Clinical response to Sorafenib in a patient with metastatic colorectal cancer and FLT3 amplification JO - Case Rep Oncol VL - 8 UR - https://doi.org/10.1159/000375483 DO - 10.1159/000375483 ID - Moreira2015 ER - TY - JOUR AU - Carvajal, R. D. AU - Antonescu, C. R. AU - Wolchok, J. D. AU - Chapman, P. B. AU - Roman, R. A. AU - Teitcher, J. PY - 2011 DA - 2011// TI - KIT as a therapeutic target in metastatic melanoma JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.746 DO - 10.1001/jama.2011.746 ID - Carvajal2011 ER - TY - JOUR AU - Tabone, S. AU - Theou, N. AU - Wozniak, A. AU - Saffroy, R. AU - Deville, L. AU - Julie, C. PY - 2005 DA - 2005// TI - KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs) JO - Biochim Biophys Acta VL - 1741 UR - https://doi.org/10.1016/j.bbadis.2005.03.011 DO - 10.1016/j.bbadis.2005.03.011 ID - Tabone2005 ER - TY - JOUR AU - Nobusawa, S. AU - Stawski, R. AU - Kim, Y. H. AU - Nakazato, Y. AU - Ohgaki, H. PY - 2011 DA - 2011// TI - Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study JO - Neuropathology VL - 31 UR - https://doi.org/10.1111/j.1440-1789.2011.01204.x DO - 10.1111/j.1440-1789.2011.01204.x ID - Nobusawa2011 ER - TY - JOUR AU - Sholl, L. M. AU - Yeap, B. Y. AU - Iafrate, A. J. AU - Holmes-Tisch, A. J. AU - Chou, Y. P. AU - Wu, M. T. PY - 2009 DA - 2009// TI - Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-2477 DO - 10.1158/0008-5472.CAN-09-2477 ID - Sholl2009 ER - TY - JOUR AU - Yu, H. A. AU - Arcila, M. E. AU - Rekhtman, N. AU - Sima, C. S. AU - Zakowski, M. F. AU - Pao, W. PY - 2013 DA - 2013// TI - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2246 DO - 10.1158/1078-0432.CCR-12-2246 ID - Yu2013 ER - TY - JOUR AU - Stransky, N. AU - Cerami, E. AU - Schalm, S. AU - Kim, J. L. AU - Lengauer, C. PY - 2014 DA - 2014// TI - The landscape of kinase fusions in cancer JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms5846 DO - 10.1038/ncomms5846 ID - Stransky2014 ER - TY - JOUR PY - 2014 DA - 2014// TI - Comprehensive molecular profiling of lung adenocarcinoma JO - Nature VL - 511 UR - https://doi.org/10.1038/nature13385 DO - 10.1038/nature13385 ID - ref95 ER - TY - JOUR AU - Brennan, C. W. AU - Verhaak, R. G. AU - McKenna, A. AU - Campos, B. AU - Noushmehr, H. AU - Salama, S. R. PY - 2013 DA - 2013// TI - The somatic genomic landscape of glioblastoma JO - Cell VL - 155 UR - https://doi.org/10.1016/j.cell.2013.09.034 DO - 10.1016/j.cell.2013.09.034 ID - Brennan2013 ER - TY - JOUR AU - Nowell, P. C. PY - 2007 DA - 2007// TI - Discovery of the Philadelphia chromosome: a personal perspective JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI31771 DO - 10.1172/JCI31771 ID - Nowell2007 ER - TY - JOUR AU - Diamond, J. AU - Goldman, J. M. AU - Melo, J. V. PY - 1995 DA - 1995// TI - BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia JO - Blood VL - 85 ID - Diamond1995 ER - TY - JOUR AU - Melo, J. V. AU - Gordon, D. E. AU - Cross, N. C. AU - Goldman, J. M. PY - 1993 DA - 1993// TI - The ABL-BCR fusion gene is expressed in chronic myeloid leukemia JO - Blood VL - 81 ID - Melo1993 ER - TY - JOUR AU - Druker, B. J. AU - Talpaz, M. AU - Resta, D. J. AU - Peng, B. AU - Buchdunger, E. AU - Ford, J. M. PY - 2001 DA - 2001// TI - Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200104053441401 DO - 10.1056/NEJM200104053441401 ID - Druker2001 ER - TY - JOUR AU - O'Brien, S. G. AU - Guilhot, F. AU - Larson, R. A. AU - Gathmann, I. AU - Baccarani, M. AU - Cervantes, F. PY - 2003 DA - 2003// TI - Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022457 DO - 10.1056/NEJMoa022457 ID - O'Brien2003 ER - TY - JOUR AU - Morris, S. W. AU - Kirstein, M. N. AU - Valentine, M. B. AU - Dittmer, K. G. AU - Shapiro, D. N. AU - Saltman, D. L. PY - 1994 DA - 1994// TI - Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma JO - Science VL - 263 UR - https://doi.org/10.1126/science.8122112 DO - 10.1126/science.8122112 ID - Morris1994 ER - TY - JOUR AU - Kutok, J. L. AU - Aster, J. C. PY - 2002 DA - 2002// TI - Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.12.033 DO - 10.1200/JCO.2002.12.033 ID - Kutok2002 ER - TY - JOUR AU - Takeuchi, K. AU - Soda, M. AU - Togashi, Y. AU - Suzuki, R. AU - Sakata, S. AU - Hatano, S. PY - 2012 DA - 2012// TI - RET, ROS1 and ALK fusions in lung cancer JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2658 DO - 10.1038/nm.2658 ID - Takeuchi2012 ER - TY - JOUR AU - Coffin, C. M. AU - Hornick, J. L. AU - Fletcher, C. D. PY - 2007 DA - 2007// TI - Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases JO - Am J Surg Pathol VL - 31 UR - https://doi.org/10.1097/01.pas.0000213393.57322.c7 DO - 10.1097/01.pas.0000213393.57322.c7 ID - Coffin2007 ER - TY - JOUR AU - Lovly, C. M. AU - Gupta, A. AU - Lipson, D. AU - Otto, G. AU - Brennan, T. AU - Chung, C. T. PY - 2014 DA - 2014// TI - Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0377 DO - 10.1158/2159-8290.CD-14-0377 ID - Lovly2014 ER - TY - JOUR AU - Wiesner, T. AU - He, J. AU - Yelensky, R. AU - Esteve-Puig, R. AU - Botton, T. AU - Yeh, I. PY - 2014 DA - 2014// TI - Kinase fusions are frequent in Spitz tumours and spitzoid melanomas JO - Nat Commun VL - 5 ID - Wiesner2014 ER - TY - JOUR AU - Lipson, D. AU - Capelletti, M. AU - Yelensky, R. AU - Otto, G. AU - Parker, A. AU - Jarosz, M. PY - 2012 DA - 2012// TI - Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2673 DO - 10.1038/nm.2673 ID - Lipson2012 ER - TY - JOUR AU - Lai, A. Z. AU - Schrock, A. B. AU - Erlich, R. L. AU - Ross, J. S. AU - Miller, V. A. AU - Yakirevich, E. PY - 2017 DA - 2017// TI - Detection of an ALK fusion in colorectal carcinoma by hybrid capture-based assay of circulating tumor DNA JO - Oncologist VL - 22 UR - https://doi.org/10.1634/theoncologist.2016-0376 DO - 10.1634/theoncologist.2016-0376 ID - Lai2017 ER - TY - JOUR AU - Chou, A. AU - Fraser, S. AU - Toon, C. W. AU - Clarkson, A. AU - Sioson, L. AU - Farzin, M. PY - 2015 DA - 2015// TI - A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma JO - Am J Surg Pathol VL - 39 UR - https://doi.org/10.1097/PAS.0000000000000368 DO - 10.1097/PAS.0000000000000368 ID - Chou2015 ER - TY - JOUR AU - Ren, H. AU - Tan, Z. P. AU - Zhu, X. AU - Crosby, K. AU - Haack, H. AU - Ren, J. M. PY - 2012 DA - 2012// TI - Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3931 DO - 10.1158/0008-5472.CAN-11-3931 ID - Ren2012 ER - TY - JOUR AU - Bergethon, K. AU - Shaw, A. T. AU - Ou, S. H. AU - Katayama, R. AU - Lovly, C. M. AU - McDonald, N. T. PY - 2012 DA - 2012// TI - ROS1 rearrangements define a unique molecular class of lung cancers JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.35.6345 DO - 10.1200/JCO.2011.35.6345 ID - Bergethon2012 ER - TY - JOUR AU - Uguen, A. AU - De Braekeleer, M. PY - 2016 DA - 2016// TI - ROS1 fusions in cancer: a review JO - Future Oncol VL - 12 UR - https://doi.org/10.2217/fon-2016-0050 DO - 10.2217/fon-2016-0050 ID - Uguen2016 ER - TY - JOUR AU - Dacic, S. AU - Luvison, A. AU - Evdokimova, V. AU - Kelly, L. AU - Siegfried, J. M. AU - Villaruz, L. C. PY - 2014 DA - 2014// TI - RET rearrangements in lung adenocarcinoma and radiation JO - J Thorac Oncol VL - 9 UR - https://doi.org/10.1097/JTO.0000000000000015 DO - 10.1097/JTO.0000000000000015 ID - Dacic2014 ER - TY - JOUR AU - Nikiforov, Y. E. PY - 2002 DA - 2002// TI - RET/PTC rearrangement in thyroid tumors JO - Endocr Pathol VL - 13 UR - https://doi.org/10.1385/EP:13:1:03 DO - 10.1385/EP:13:1:03 ID - Nikiforov2002 ER - TY - STD TI - Hyman DM, Laetsch TW, Kummar S, DuBois SG, Farago AF, Pappo AS, et al. The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers. J Clin Oncol. 2017. https://doi.org/10.1200/JCO.2017.35.15_suppl.LBA2501. ID - ref116 ER - TY - JOUR AU - Konduri, K. AU - Gallant, J. N. AU - Chae, Y. K. AU - Giles, F. J. AU - Gitlitz, B. J. AU - Gowen, K. PY - 2016 DA - 2016// TI - EGFR fusions as novel therapeutic targets in lung cancer JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0075 DO - 10.1158/2159-8290.CD-16-0075 ID - Konduri2016 ER - TY - JOUR AU - Chmielecki, J. AU - Ross, J. S. AU - Wang, K. AU - Frampton, G. M. AU - Palmer, G. A. AU - Ali, S. M. PY - 2015 DA - 2015// TI - Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin JO - Oncologist VL - 20 UR - https://doi.org/10.1634/theoncologist.2014-0234 DO - 10.1634/theoncologist.2014-0234 ID - Chmielecki2015 ER - TY - JOUR AU - Huang, Q. AU - Snyder, D. S. AU - Chu, P. AU - Gaal, K. K. AU - Chang, K. L. AU - Weiss, L. M. PY - 2011 DA - 2011// TI - PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia JO - Leukemia VL - 25 UR - https://doi.org/10.1038/leu.2010.272 DO - 10.1038/leu.2010.272 ID - Huang2011 ER - TY - JOUR AU - Ito, T. AU - Seyama, T. AU - Iwamoto, K. S. AU - Hayashi, T. AU - Mizuno, T. AU - Tsuyama, N. PY - 1993 DA - 1993// TI - In vitro irradiation is able to cause RET oncogene rearrangement JO - Cancer Res VL - 53 ID - Ito1993 ER - TY - JOUR AU - Mizuno, T. AU - Kyoizumi, S. AU - Suzuki, T. AU - Iwamoto, K. S. AU - Seyama, T. PY - 1997 DA - 1997// TI - Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis JO - Oncogene VL - 15 UR - https://doi.org/10.1038/sj.onc.1201313 DO - 10.1038/sj.onc.1201313 ID - Mizuno1997 ER - TY - JOUR AU - Mistry, A. R. AU - Felix, C. A. AU - Whitmarsh, R. J. AU - Mason, A. AU - Reiter, A. AU - Cassinat, B. PY - 2005 DA - 2005// TI - DNA topoisomerase II in therapy-related acute promyelocytic leukemia JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa042715 DO - 10.1056/NEJMoa042715 ID - Mistry2005 ER - TY - JOUR AU - Tsai, A. G. AU - Lieber, M. R. PY - 2010 DA - 2010// TI - Mechanisms of chromosomal rearrangement in the human genome JO - BMC Genomics VL - 11 UR - https://doi.org/10.1186/1471-2164-11-S1-S1 DO - 10.1186/1471-2164-11-S1-S1 ID - Tsai2010 ER - TY - JOUR AU - Soda, M. AU - Choi, Y. L. AU - Enomoto, M. AU - Takada, S. AU - Yamashita, Y. AU - Ishikawa, S. PY - 2007 DA - 2007// TI - Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05945 DO - 10.1038/nature05945 ID - Soda2007 ER - TY - JOUR AU - Noh, K. W. AU - Lee, M. S. AU - Lee, S. E. AU - Song, J. Y. AU - Shin, H. T. AU - Kim, Y. J. PY - 2017 DA - 2017// TI - Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer JO - J Pathol VL - 243 UR - https://doi.org/10.1002/path.4950 DO - 10.1002/path.4950 ID - Noh2017 ER - TY - JOUR AU - Ju, Y. S. AU - Lee, W. C. AU - Shin, J. Y. AU - Lee, S. AU - Bleazard, T. AU - Won, J. K. PY - 2012 DA - 2012// TI - A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing JO - Genome Res VL - 22 UR - https://doi.org/10.1101/gr.133645.111 DO - 10.1101/gr.133645.111 ID - Ju2012 ER - TY - JOUR AU - Wu, Y. M. AU - Su, F. AU - Kalyana-Sundaram, S. AU - Khazanov, N. AU - Ateeq, B. AU - Cao, X. PY - 2013 DA - 2013// TI - Identification of targetable FGFR gene fusions in diverse cancers JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-13-0050 DO - 10.1158/2159-8290.CD-13-0050 ID - Wu2013 ER - TY - JOUR AU - Ross, T. S. AU - Gilliland, D. G. PY - 1999 DA - 1999// TI - Transforming properties of the huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.32.22328 DO - 10.1074/jbc.274.32.22328 ID - Ross1999 ER - TY - JOUR AU - Martelli, M. P. AU - Sozzi, G. AU - Hernandez, L. AU - Pettirossi, V. AU - Navarro, A. AU - Conte, D. PY - 2009 DA - 2009// TI - EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues JO - Am J Pathol VL - 174 UR - https://doi.org/10.2353/ajpath.2009.080755 DO - 10.2353/ajpath.2009.080755 ID - Martelli2009 ER - TY - JOUR AU - Corvi, R. AU - Berger, N. AU - Balczon, R. AU - Romeo, G. PY - 2000 DA - 2000// TI - RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203772 DO - 10.1038/sj.onc.1203772 ID - Corvi2000 ER - TY - JOUR AU - Iragavarapu, C. AU - Mustafa, M. AU - Akinleye, A. AU - Furqan, M. AU - Mittal, V. AU - Cang, S. PY - 2015 DA - 2015// TI - Novel ALK inhibitors in clinical use and development JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0122-8 DO - 10.1186/s13045-015-0122-8 ID - Iragavarapu2015 ER - TY - JOUR AU - Butrynski, J. E. AU - D'Adamo, D. R. AU - Hornick, J. L. AU - Dal Cin, P. AU - Antonescu, C. R. AU - Jhanwar, S. C. PY - 2010 DA - 2010// TI - Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1007056 DO - 10.1056/NEJMoa1007056 ID - Butrynski2010 ER - TY - JOUR AU - Kwak, E. L. AU - Bang, Y. J. AU - Camidge, D. R. AU - Shaw, A. T. AU - Solomon, B. AU - Maki, R. G. PY - 2010 DA - 2010// TI - Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1006448 DO - 10.1056/NEJMoa1006448 ID - Kwak2010 ER - TY - JOUR AU - Kloos, R. T. AU - Ringel, M. D. AU - Knopp, M. V. AU - Hall, N. C. AU - King, M. AU - Stevens, R. PY - 2009 DA - 2009// TI - Phase II trial of sorafenib in metastatic thyroid cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.2717 DO - 10.1200/JCO.2008.18.2717 ID - Kloos2009 ER - TY - JOUR AU - Wang, R. AU - Hu, H. AU - Pan, Y. AU - Li, Y. AU - Ye, T. AU - Li, C. PY - 2012 DA - 2012// TI - RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.44.1477 DO - 10.1200/JCO.2012.44.1477 ID - Wang2012 ER - TY - JOUR AU - Drilon, A. AU - Wang, L. AU - Hasanovic, A. AU - Suehara, Y. AU - Lipson, D. AU - Stephens, P. PY - 2013 DA - 2013// TI - Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-13-0035 DO - 10.1158/2159-8290.CD-13-0035 ID - Drilon2013 ER - TY - JOUR AU - Drilon, A. AU - Rekhtman, N. AU - Arcila, M. AU - Wang, L. AU - Ni, A. AU - Albano, M. PY - 2016 DA - 2016// TI - Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30562-9 DO - 10.1016/S1470-2045(16)30562-9 ID - Drilon2016 ER - TY - JOUR AU - Kiehna, E. N. AU - Arnush, M. R. AU - Tamrazi, B. AU - Cotter, J. A. AU - Hawes, D. AU - Robison, N. J. PY - 2017 DA - 2017// TI - Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor JO - J Neurosurg Pediatr VL - 20 UR - https://doi.org/10.3171/2017.2.PEDS16679 DO - 10.3171/2017.2.PEDS16679 ID - Kiehna2017 ER - TY - JOUR AU - Shaw, A. T. AU - Solomon, B. J. PY - 2015 DA - 2015// TI - Crizotinib in ROS1-rearranged non-small-cell lung cancer JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMc1415359 DO - 10.1056/NEJMc1415359 ID - Shaw2015 ER - TY - JOUR AU - Drilon, A. AU - Nagasubramanian, R. AU - Blake, J. F. AU - Ku, N. AU - Tuch, B. B. AU - Ebata, K. PY - 2017 DA - 2017// TI - A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-17-0507 DO - 10.1158/2159-8290.CD-17-0507 ID - Drilon2017 ER - TY - JOUR AU - Drilon, A. AU - Siena, S. AU - Ou, S. I. AU - Patel, M. AU - Ahn, M. J. AU - Lee, J. PY - 2017 DA - 2017// TI - Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor Entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1) JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-1237 DO - 10.1158/2159-8290.CD-16-1237 ID - Drilon2017 ER - TY - JOUR AU - Chen, H. Y. AU - Brady, D. C. AU - Villanueva, J. PY - 2016 DA - 2016// TI - Double trouble: kinase domain duplication as a new path to drug resistance JO - Pigment Cell Melanoma Res VL - 29 UR - https://doi.org/10.1111/pcmr.12508 DO - 10.1111/pcmr.12508 ID - Chen2016 ER - TY - JOUR AU - Gallant, J. N. AU - Sheehan, J. H. AU - Shaver, T. M. AU - Bailey, M. AU - Lipson, D. AU - Chandramohan, R. PY - 2015 DA - 2015// TI - EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to Afatinib JO - Cancer Discov VL - 5 UR - https://doi.org/10.1158/2159-8290.CD-15-0654 DO - 10.1158/2159-8290.CD-15-0654 ID - Gallant2015 ER - TY - JOUR AU - Rodriguez, F. J. AU - Ligon, A. H. AU - Horkayne-Szakaly, I. AU - Rushing, E. J. AU - Ligon, K. L. AU - Vena, N. PY - 2012 DA - 2012// TI - BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper JO - J Neuropathol Exp Neurol VL - 71 UR - https://doi.org/10.1097/NEN.0b013e3182656ef8 DO - 10.1097/NEN.0b013e3182656ef8 ID - Rodriguez2012 ER - TY - JOUR AU - Klempner, S. J. AU - Bordoni, R. AU - Gowen, K. AU - Kaplan, H. AU - Stephens, P. J. AU - Ou, S. H. PY - 2016 DA - 2016// TI - Identification of BRAF kinase domain duplications across multiple tumor types and response to RAF inhibitor therapy JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2015.4437 DO - 10.1001/jamaoncol.2015.4437 ID - Klempner2016 ER - TY - JOUR AU - Gay, L. M. AU - Pavlick, D. AU - Chung, J. AU - Ramkissoon, S. AU - Daniel, S. AU - Elvin, J. A. PY - 2017 DA - 2017// TI - Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types JO - Ann Oncol VL - 28 ID - Gay2017 ER - TY - JOUR AU - Kondrashov, F. A. PY - 2012 DA - 2012// TI - Gene duplication as a mechanism of genomic adaptation to a changing environment JO - Proc Biol Sci VL - 279 UR - https://doi.org/10.1098/rspb.2012.1108 DO - 10.1098/rspb.2012.1108 ID - Kondrashov2012 ER - TY - JOUR AU - Poulikakos, P. I. AU - Persaud, Y. AU - Janakiraman, M. AU - Kong, X. AU - Ng, C. AU - Moriceau, G. PY - 2011 DA - 2011// TI - RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10662 DO - 10.1038/nature10662 ID - Poulikakos2011 ER - TY - JOUR AU - Singh, A. B. AU - Harris, R. C. PY - 2005 DA - 2005// TI - Autocrine, paracrine and juxtacrine signaling by EGFR ligands JO - Cell Signal VL - 17 UR - https://doi.org/10.1016/j.cellsig.2005.03.026 DO - 10.1016/j.cellsig.2005.03.026 ID - Singh2005 ER - TY - JOUR AU - Walsh, J. H. AU - Karnes, W. E. AU - Cuttitta, F. AU - Walker, A. PY - 1991 DA - 1991// TI - Autocrine growth factors and solid tumor malignancy JO - West J Med VL - 155 ID - Walsh1991 ER - TY - JOUR AU - Ciardiello, F. AU - Tortora, G. PY - 2001 DA - 2001// TI - A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor JO - Clin Cancer Res VL - 7 ID - Ciardiello2001 ER - TY - JOUR AU - Kentsis, A. AU - Reed, C. AU - Rice, K. L. AU - Sanda, T. AU - Rodig, S. J. AU - Tholouli, E. PY - 2012 DA - 2012// TI - Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2819 DO - 10.1038/nm.2819 ID - Kentsis2012 ER - TY - JOUR AU - Yi, S. AU - Tsao, M. S. PY - 2000 DA - 2000// TI - Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line JO - Neoplasia VL - 2 UR - https://doi.org/10.1038/sj.neo.7900080 DO - 10.1038/sj.neo.7900080 ID - Yi2000 ER - TY - JOUR AU - Krystal, G. W. AU - Hines, S. J. AU - Organ, C. P. PY - 1996 DA - 1996// TI - Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor JO - Cancer Res VL - 56 ID - Krystal1996 ER - TY - JOUR AU - Wiesner, C. AU - Nabha, S. M. AU - Dos Santos, E. B. AU - Yamamoto, H. AU - Meng, H. AU - Melchior, S. W. PY - 2008 DA - 2008// TI - C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis JO - Neoplasia VL - 10 UR - https://doi.org/10.1593/neo.08618 DO - 10.1593/neo.08618 ID - Wiesner2008 ER - TY - JOUR AU - Esposito, I. AU - Kleeff, J. AU - Bischoff, S. C. AU - Fischer, L. AU - Collecchi, P. AU - Iorio, M. PY - 2002 DA - 2002// TI - The stem cell factor-c-kit system and mast cells in human pancreatic cancer JO - Lab Investig VL - 82 UR - https://doi.org/10.1097/01.LAB.0000036875.21209.F9 DO - 10.1097/01.LAB.0000036875.21209.F9 ID - Esposito2002 ER - TY - JOUR AU - Fujimoto, N. AU - Wislez, M. AU - Zhang, J. AU - Iwanaga, K. AU - Dackor, J. AU - Hanna, A. E. PY - 2005 DA - 2005// TI - High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-1977 DO - 10.1158/0008-5472.CAN-05-1977 ID - Fujimoto2005 ER - TY - JOUR AU - Donzelli, S. AU - Cioce, M. AU - Muti, P. AU - Strano, S. AU - Yarden, Y. AU - Blandino, G. PY - 2016 DA - 2016// TI - MicroRNAs: non-coding fine tuners of receptor tyrosine kinase signalling in cancer JO - Semin Cell Dev Biol VL - 50 UR - https://doi.org/10.1016/j.semcdb.2015.12.020 DO - 10.1016/j.semcdb.2015.12.020 ID - Donzelli2016 ER - TY - JOUR AU - Yan, Y. AU - Luo, Y. C. AU - Wan, H. Y. AU - Wang, J. AU - Zhang, P. P. AU - Liu, M. PY - 2013 DA - 2013// TI - MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells JO - Hepatology VL - 57 UR - https://doi.org/10.1002/hep.26071 DO - 10.1002/hep.26071 ID - Yan2013 ER - TY - JOUR AU - Cho, W. C. AU - Chow, A. S. AU - Au, J. S. PY - 2011 DA - 2011// TI - MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1 JO - RNA Biol VL - 8 UR - https://doi.org/10.4161/rna.8.1.14259 DO - 10.4161/rna.8.1.14259 ID - Cho2011 ER - TY - JOUR AU - Rao, S. A. AU - Arimappamagan, A. AU - Pandey, P. AU - Santosh, V. AU - Hegde, A. S. AU - Chandramouli, B. A. PY - 2013 DA - 2013// TI - miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0063164 DO - 10.1371/journal.pone.0063164 ID - Rao2013 ER - TY - JOUR AU - Zhang, Y. AU - Kim, J. AU - Mueller, A. C. AU - Dey, B. AU - Yang, Y. AU - Lee, D. H. PY - 2014 DA - 2014// TI - Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma JO - Cell Death Differ VL - 21 UR - https://doi.org/10.1038/cdd.2013.196 DO - 10.1038/cdd.2013.196 ID - Zhang2014 ER - TY - JOUR AU - Zhang, K. L. AU - Han, L. AU - Chen, L. Y. AU - Shi, Z. D. AU - Yang, M. AU - Ren, Y. PY - 2014 DA - 2014// TI - Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas JO - Cancer Lett VL - 342 UR - https://doi.org/10.1016/j.canlet.2013.08.043 DO - 10.1016/j.canlet.2013.08.043 ID - Zhang2014 ER - TY - JOUR AU - Cappuzzo, F. AU - Sacconi, A. AU - Landi, L. AU - Ludovini, V. AU - Biagioni, F. AU - D'Incecco, A. PY - 2014 DA - 2014// TI - MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies JO - Clin Colorectal Cancer VL - 13 UR - https://doi.org/10.1016/j.clcc.2013.11.006 DO - 10.1016/j.clcc.2013.11.006 ID - Cappuzzo2014 ER - TY - JOUR AU - Spill, F. AU - Reynolds, D. S. AU - Kamm, R. D. AU - Zaman, M. H. PY - 2016 DA - 2016// TI - Impact of the physical microenvironment on tumor progression and metastasis JO - Curr Opin Biotechnol VL - 40 UR - https://doi.org/10.1016/j.copbio.2016.02.007 DO - 10.1016/j.copbio.2016.02.007 ID - Spill2016 ER - TY - JOUR AU - Brantley-Sieders, D. AU - Schmidt, S. AU - Parker, M. AU - Chen, J. PY - 2004 DA - 2004// TI - Eph receptor tyrosine kinases in tumor and tumor microenvironment JO - Curr Pharm Des VL - 10 UR - https://doi.org/10.2174/1381612043383160 DO - 10.2174/1381612043383160 ID - Brantley-Sieders2004 ER - TY - STD TI - Rankin EB, Giaccia AJ. The Receptor Tyrosine Kinase AXL in Cancer Progression. Cancers (Basel). 2016. https://doi.org/10.3390/cancers8110103. ID - ref167 ER - TY - JOUR AU - Gattei, V. AU - Celetti, A. AU - Cerrato, A. AU - Degan, M. AU - De Iuliis, A. AU - Rossi, F. M. PY - 1997 DA - 1997// TI - Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment JO - Blood VL - 89 ID - Gattei1997 ER - TY - JOUR AU - Ribatti, D. AU - Ranieri, G. AU - Basile, A. AU - Azzariti, A. AU - Paradiso, A. AU - Vacca, A. PY - 2012 DA - 2012// TI - Tumor endothelial markers as a target in cancer JO - Expert Opin Ther Targets VL - 16 UR - https://doi.org/10.1517/14728222.2012.725047 DO - 10.1517/14728222.2012.725047 ID - Ribatti2012 ER - TY - JOUR AU - Bertolini, F. AU - Mancuso, P. AU - Benayoun, L. AU - Gingis-Velitski, S. AU - Shaked, Y. PY - 2012 DA - 2012// TI - Evaluation of circulating endothelial precursor cells in cancer patients JO - Methods Mol Biol VL - 904 ID - Bertolini2012 ER - TY - JOUR AU - Gialeli, C. AU - Nikitovic, D. AU - Kletsas, D. AU - Theocharis, A. D. AU - Tzanakakis, G. N. AU - Karamanos, N. K. PY - 2014 DA - 2014// TI - PDGF/PDGFR signaling and targeting in cancer growth and progression: focus on tumor microenvironment and cancer-associated fibroblasts JO - Curr Pharm Des VL - 20 UR - https://doi.org/10.2174/13816128113199990592 DO - 10.2174/13816128113199990592 ID - Gialeli2014 ER - TY - STD TI - Worby CA, Dixon JE. PTEN. Annu Rev Biochem. 2014;83:641–69. ID - ref172 ER - TY - JOUR AU - Gur, G. AU - Rubin, C. AU - Katz, M. AU - Amit, I. AU - Citri, A. AU - Nilsson, J. PY - 2004 DA - 2004// TI - LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation JO - EMBO J VL - 23 UR - https://doi.org/10.1038/sj.emboj.7600342 DO - 10.1038/sj.emboj.7600342 ID - Gur2004 ER - TY - JOUR AU - Zhang, X. AU - Pickin, K. A. AU - Bose, R. AU - Jura, N. AU - Cole, P. A. AU - Kuriyan, J. PY - 2007 DA - 2007// TI - Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface JO - Nature VL - 450 UR - https://doi.org/10.1038/nature05998 DO - 10.1038/nature05998 ID - Zhang2007 ER - TY - JOUR AU - Bagchi, A. AU - Mills, A. A. PY - 2008 DA - 2008// TI - The quest for the 1p36 tumor suppressor JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2095 DO - 10.1158/0008-5472.CAN-07-2095 ID - Bagchi2008 ER - TY - JOUR AU - Koshikawa, K. AU - Nomoto, S. AU - Yamashita, K. AU - Ishigure, K. AU - Takeda, S. AU - Nakao, A. PY - 2004 DA - 2004// TI - Allelic imbalance at 1p36 in the pathogenesis of human hepatocellular carcinoma JO - Hepato-Gastroenterology VL - 51 ID - Koshikawa2004 ER - TY - JOUR AU - Tseng, R. C. AU - Chang, J. W. AU - Hsien, F. J. AU - Chang, Y. H. AU - Hsiao, C. F. AU - Chen, J. T. PY - 2005 DA - 2005// TI - Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer JO - Int J Cancer VL - 117 UR - https://doi.org/10.1002/ijc.21178 DO - 10.1002/ijc.21178 ID - Tseng2005 ER - TY - JOUR AU - Ferby, I. AU - Reschke, M. AU - Kudlacek, O. AU - Knyazev, P. AU - Pante, G. AU - Amann, K. PY - 2006 DA - 2006// TI - Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation JO - Nat Med VL - 12 UR - https://doi.org/10.1038/nm1401 DO - 10.1038/nm1401 ID - Ferby2006 ER - TY - JOUR AU - Amatschek, S. AU - Koenig, U. AU - Auer, H. AU - Steinlein, P. AU - Pacher, M. AU - Gruenfelder, A. PY - 2004 DA - 2004// TI - Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2361 DO - 10.1158/0008-5472.CAN-03-2361 ID - Amatschek2004 ER - TY - JOUR AU - Shawver, L. K. AU - Slamon, D. AU - Ullrich, A. PY - 2002 DA - 2002// TI - Smart drugs: tyrosine kinase inhibitors in cancer therapy JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(02)00039-9 DO - 10.1016/S1535-6108(02)00039-9 ID - Shawver2002 ER - TY - JOUR AU - Pirker, R. AU - Pereira, J. R. AU - Szczesna, A. AU - von Pawel, J. AU - Krzakowski, M. AU - Ramlau, R. PY - 2009 DA - 2009// TI - Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60569-9 DO - 10.1016/S0140-6736(09)60569-9 ID - Pirker2009 ER - TY - JOUR AU - Gibson, T. B. AU - Ranganathan, A. AU - Grothey, A. PY - 2006 DA - 2006// TI - Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer JO - Clin Colorectal Cancer VL - 6 UR - https://doi.org/10.3816/CCC.2006.n.01 DO - 10.3816/CCC.2006.n.01 ID - Gibson2006 ER - TY - JOUR AU - Vermorken, J. B. AU - Mesia, R. AU - Rivera, F. AU - Remenar, E. AU - Kawecki, A. AU - Rottey, S. PY - 2008 DA - 2008// TI - Platinum-based chemotherapy plus cetuximab in head and neck cancer JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0802656 DO - 10.1056/NEJMoa0802656 ID - Vermorken2008 ER - TY - JOUR AU - Romond, E. H. AU - Perez, E. A. AU - Bryant, J. AU - Suman, V. J. AU - Geyer, C. E. AU - Davidson, N. E. PY - 2005 DA - 2005// TI - Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa052122 DO - 10.1056/NEJMoa052122 ID - Romond2005 ER - TY - JOUR AU - von Minckwitz, G. AU - Procter, M. AU - de Azambuja, E. AU - Zardavas, D. AU - Benyunes, M. AU - Viale, G. PY - 2017 DA - 2017// TI - Adjuvant Pertuzumab and Trastuzumab in early HER2-positive breast cancer JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1703643 DO - 10.1056/NEJMoa1703643 ID - von Minckwitz2017 ER - TY - JOUR AU - Kobayashi, S. AU - Boggon, T. J. AU - Dayaram, T. AU - Janne, P. A. AU - Kocher, O. AU - Meyerson, M. PY - 2005 DA - 2005// TI - EGFR mutation and resistance of non-small-cell lung cancer to gefitinib JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa044238 DO - 10.1056/NEJMoa044238 ID - Kobayashi2005 ER - TY - JOUR AU - Sasaki, T. AU - Koivunen, J. AU - Ogino, A. AU - Yanagita, M. AU - Nikiforow, S. AU - Zheng, W. PY - 2011 DA - 2011// TI - A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-1340 DO - 10.1158/0008-5472.CAN-11-1340 ID - Sasaki2011 ER - TY - JOUR AU - Engelman, J. A. AU - Janne, P. A. AU - Mermel, C. AU - Pearlberg, J. AU - Mukohara, T. AU - Fleet, C. PY - 2005 DA - 2005// TI - ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0409773102 DO - 10.1073/pnas.0409773102 ID - Engelman2005 ER - TY - JOUR AU - Hrustanovic, G. AU - Olivas, V. AU - Pazarentzos, E. AU - Tulpule, A. AU - Asthana, S. AU - Blakely, C. M. PY - 2015 DA - 2015// TI - RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3930 DO - 10.1038/nm.3930 ID - Hrustanovic2015 ER - TY - JOUR AU - Blakely, C. M. AU - Pazarentzos, E. AU - Olivas, V. AU - Asthana, S. AU - Yan, J. J. AU - Tan, I. PY - 2015 DA - 2015// TI - NF-kappaB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer JO - Cell Rep VL - 11 UR - https://doi.org/10.1016/j.celrep.2015.03.012 DO - 10.1016/j.celrep.2015.03.012 ID - Blakely2015 ER - TY - JOUR AU - Li, D. AU - Ambrogio, L. AU - Shimamura, T. AU - Kubo, S. AU - Takahashi, M. AU - Chirieac, L. R. PY - 2008 DA - 2008// TI - BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.109 DO - 10.1038/onc.2008.109 ID - Li2008 ER - TY - JOUR AU - Kwak, E. L. AU - Sordella, R. AU - Bell, D. W. AU - Godin-Heymann, N. AU - Okimoto, R. A. AU - Brannigan, B. W. PY - 2005 DA - 2005// TI - Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0502860102 DO - 10.1073/pnas.0502860102 ID - Kwak2005 ER - TY - JOUR AU - Finlay, M. R. AU - Anderton, M. AU - Ashton, S. AU - Ballard, P. AU - Bethel, P. A. AU - Box, M. R. PY - 2014 DA - 2014// TI - Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor JO - J Med Chem VL - 57 UR - https://doi.org/10.1021/jm500973a DO - 10.1021/jm500973a ID - Finlay2014 ER - TY - JOUR AU - Soria, J. C. AU - Ohe, Y. AU - Vansteenkiste, J. AU - Reungwetwattana, T. AU - Chewaskulyong, B. AU - Lee, K. H. PY - 2018 DA - 2018// TI - Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1713137 DO - 10.1056/NEJMoa1713137 ID - Soria2018 ER - TY - JOUR AU - Janjigian, Y. Y. AU - Smit, E. F. AU - Groen, H. J. AU - Horn, L. AU - Gettinger, S. AU - Camidge, D. R. PY - 2014 DA - 2014// TI - Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutations JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0326 DO - 10.1158/2159-8290.CD-14-0326 ID - Janjigian2014 ER -